Surveillance for Streptococcus pneumoniae meningitis in children aged <5 years: Implications for immunization in Uganda

Clinical Infectious Diseases

Volumn 48, Issue SUPPL. 2, 2009, Pages

  Kisakye, Annet ^a   Makumbi, Issa ^a   Nansera, Denis ^d   Lewis, Rosamund ^b   Braka, Fiona ^b   Wobudeya, Eric ^c   Chaplain, Duku ^c   Nalumansi, Esther ^c   Mbabazi, William ^b   Gessner, Bradford D ^e  

^a MINISTRY OF HEALTH   (Uganda)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c MULAGO NATIONAL REFERRAL HOSPITAL   (Uganda)

^d Mbarara University Teaching Hospital   (Uganda)

^e Agence de Medecine Preventive   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PENICILLIN DERIVATIVE; PNEUMOCOCCUS VACCINE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL MENINGITIS; BACTERIUM ISOLATE; CEREBROSPINAL FLUID CULTURE; CHILD; DISEASE SURVEILLANCE; HUMAN; IMMUNIZATION; INCIDENCE; LEUKOCYTE COUNT; LUMBAR PUNCTURE; MAJOR CLINICAL STUDY; MORTALITY; PNEUMOCOCCAL MENINGITIS; PRIORITY JOURNAL; SALMONELLA; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; UGANDA; VACCINATION;

ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; CHILD, PRESCHOOL; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MENINGITIS, PNEUMOCOCCAL; MICROBIAL SENSITIVITY TESTS; PNEUMOCOCCAL VACCINES; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; UGANDA;

EID: 61849099863     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/596495     Document Type: Article

References (24)

1. World Health Organization (WHO). Pneumococcal vaccines. WHO position paper. Wkly Epidemiol Rec 2003; 78:110-9. Available at: http:// www.who.int/immunization/wer7814pneumococcal-Apr03-position-paper.pdf. Accessed 11 January 2009.
2. O'Dempsey TJ, McArdle TF, Lloyd-Evans N, et al. Pneumococcal disease among children in a rural area of west Africa. Pediatr Infect Dis J 1996; 15:431-7.
3. Campbell JD, Kotloff KL, Sow SO, et al. Invasive pneumococcal infections among hospitalized children in Bamako, Mali. Pediatr Infect Dis J 2004; 23:642-9.
4. Roca A, Sigauque B, Quinto L, et al. Invasive pneumococcal disease in children <5 years of age in rural Mozambique. Trop Med Int Health 2006; 11:1422-31.
5. Leimkugel J, Forgor AA, Gagneux S, et al. An outbreak of serotype 1 streptococcus pneumoniae meningitis in Northern Ghana with features that are characteristic of Neisseria meningitidis meningitis epidemics. J Infect Dis 2005; 192:192-9.
6. Yaro S, Lourd M, Traore Y, et al. Epidemiological and molecular characteristics of a highly lethal pneumococcal meningitis epidemic in Burkina Faso. Clin Infect Dis 2006; 43:693-700.
7. Cutts FT, Zaman SM, Enwere G, et al. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet 2005; 365:1139-46.
8. Klugman KP, Madhi SA, Huebner RE, et al. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med 2003; 349:1341-8.
9. GAVI Alliance announces funding for new vaccines against two major killers of children in poorest nations. Berlin Press Briefing. Available at: http://www.gavialliance.org/media-centre/press-releases/2006-11 -29-en-pr-berlin-newvaccines.php. Accessed 11 January 2009.
10. World Health Organization (WHO). Hib Paediatric Bacterial Meningitis Surveillance Network overview. Available at: http://www.afro.who.int/hib. Accessed 11 May 2007.
11. The Network for Surveillance of Pneumococcal Disease in the East African Region. Available at: http://www.netspear.org. Accessed 11 May 2007.
12. Uganda Bureau of Statistics 2006 Statistical Abstract. Available at: http: //www.ubos.org/2006StatAbstract.pdf. Accessed 17 August 2007.
13. United Nations Children's Fund. The state of the world's children 2001, table 2: nutrition. Available at: http://www.unicef.org/sowc01/tables/ table8.htm. Accessed 7 April 2007.
14. United Nations Children's Fund. The state of the world's children 2007. Available at: http://www.unicef.org/infobycountry/uganda-statistics .html. Accessed 7 April 2007.
15. Collee G. Mackie and McCartney's practical medical microbiology. 14th ed. Edinburgh, Scotland: Churchill Livingston, 1996:279-280.
16. National Committee for Clinical Laboratory Standards. Antimicrobial disk susceptibility testing standards. Document M2-A9, M7-A7. Wayne, PA: National Committee for Clinical Laboratory Standards, 2006.
17. Lewis RF, Kisakye A, Gessner BD, et al. Action for child survival: elimination of Haemophilus influenzae type b meningitis in Uganda. Bull World Health Organ 2008; 86:292-301.
18. Peltola H. Burden of meningitis and other severe bacterial infections of children in Africa: implications for prevention. Clin Infect Dis 2001; 32:64-75.
19. Adegbola RA, Hill PC, Secka O, et al. Serotype and antimicrobial susceptibility patterns of isolates of Streptococcus pneumoniae causing invasive disease in The Gambia 1996-2003. Trop Med Int Health 2006; 11:1128-35.
20. Hausdorff WP, Feikin D, Klugman KP. Epidemiological differences among pneumococcal serotypes. Lancet Infect Dis 2005; 5:83-93.
21. Klugman KP, Madhi SA, Feldman C. HIV and pneumococcal disease. Curr Opin Infect Dis 2007; 20:11-5.
22. Madhi SA, Adrian P, Kuwanda L, Cutland C, Albrich WC, Klugman KP. Long-term effect of pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae - and associated interactions with Staphylococcus aureus and Haemophilus influenzae colonization - in HIV-Infected and HIV-uninfected children. J Infect Dis 2007; 196:1662-6.
23. Madhi SA, Adrian P, Kuwanda L, et al. Long-term immunogenicity and efficacy of a 9-valent conjugate pneumococcal vaccine in human immunodeficient virus infected and non-infected children in the absence of a booster dose of vaccine. Vaccine 2007; 25:2451-7.
24. Advance Market Commitments for Vaccines. Available at: http:// www.vaccineamc.org. Accessed 17 May 2007.